Picture of Dextech Medical AB logo

DEX Dextech Medical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: DexTech Gets Positive Results Regarding Multiple Myeloma

Feb 2 (Reuters) - DexTech Medical AB  DEXTECH.TE :
    * SAID ON MONDAY IT RECEIVES POSITIVE RESULTS REGARDING
MULTIPLE
MYELOMA
    * SEES OSTEODEX AS VERY PROMISING FOR THE TREATMENT OF MM
    * OBSERVED CELL KILLING EFFECT IS SUPERIOR TO THE COMPARED
SUBSTANCE, MELPHALAN, WHICH IS A STANDARD DRUG IN THE TREATMENT
OF MM

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr8pPrT
    
 Further company coverage:  DEXTECH.TE  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))

Recent news on Dextech Medical AB

See all news